Hepatitis: all 3,372 studies
Page 26 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or RibavirinTerminatedNCT01425970Phase 2
- HCV/HIV Coinfection: Antiviral Therapy and FibrosisCompletedNCT01423643
- Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver TransplantationCompletedNCT01421212Phase 1/2
- Increasing Viral Testing in the Emergency DepartmentCompletedNCT01419899Phase 2/3
- Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC PolymorphismWithdrawnNCT01415141Phase 4
- Hepatitis C Rimantadine and Antiviral Combination TherapyCompletedNCT01413490
- Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ MothersCompletedNCT01412567Not applicable
- Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASHTerminatedNCT01406704Phase 4
- Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A VaccineCompletedNCT01405677Phase 2
- Association Between Hepatitis C Infection and Renal Cell CarcinomaCompletedNCT01405183
- Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis CCompletedNCT01402583
- Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B StudyCompletedNCT01401400
- Reintroduction Regimens After Hepatitis During Anti-tuberculosis TreatmentStatus unknownNCT01395654Phase 4
- TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined With Pegylated Interferon + RibavirinTerminatedNCT01391117Phase 1
- A Two Week Dosing Study to Determine the Safety and Antiviral Activity of LCQ908 in Hepatitis C PatientsTerminatedNCT01387958Phase 2
- GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC GenotypeTerminatedNCT01384383Phase 2
- TMC435-TiDP16-C126 - Trial to Investigate the Effect of Severe Renal Impairment on the Pharmacokinetics and Safety of TMC435CompletedNCT01381835Phase 1
- Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)Status unknownNCT01380951Phase 4
- HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon SensitivityTerminatedNCT01377909Phase 1
- NASVAC Phase-III Trial in Chronic Hepatitis B (CHB) PatientsStatus unknownNCT01374308Phase 3
- PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B PatientsCompletedNCT01373684Phase 4
- Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks (MK-2355-005)CompletedNCT01371604Phase 2
- Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus InfectionCompletedNCT01371578Phase 2
- A Study of RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis CCompletedNCT01371162Phase 1
- Hepatitis A Vaccine in Patients With Immunomodulating DrugsCompletedNCT01360970Phase 2
- Prediction of Incidence of Liver Cancer by Use of Real-time Tissue ElastographyStatus unknownNCT01360892
- Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver DiseaseStatus unknownNCT01360879
- Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B PatientsCompletedNCT01356901
- GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C VirusCompletedNCT01356160Phase 2
- Hepatitis A Vaccination in the ElderlyCompletedNCT01353989
- GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) InfectionCompletedNCT01353248Phase 2
- Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV InfectionCompletedNCT01350648
- An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)CompletedNCT01344889
- Efficacy of Medical Ozone Therapy in Patients With Chronic Hepatitis BStatus unknownNCT01342185Phase 3
- Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) PatientsCompletedNCT01341808Phase 4
- Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownNCT01341743Phase 4
- Adolescents' Response to Hepatitis B Vaccine Booster DoseStatus unknownNCT01341275Phase 4
- Induction of Fibrosis Regression on Patients With Chronic Hepatitis B InfectionTerminatedNCT01341106Phase 4
- Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase LevelsCompletedNCT01337791Phase 4
- A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) TrialsCompletedNCT01337479
- A Study of the Pharmacokinetics And Pharmacodynamics of Intravenously Administered Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C And Previous Non-Response to Pegylated Interferon And Ribavirin Combination TherapyCompletedNCT01337375Phase 1
- TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.CompletedNCT01336829Phase 1
- Treatment of Recently Acquired Hepatitis C Virus InfectionCompletedNCT01336010Phase 4
- CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) SubjectsStatus unknownNCT01335711Phase 2
- A Open-label Study to Evaluate the Relative Bioavailability of Samatasvir (IDX184) and Food Effect in Healthy Male Participants (MK-2355-006)CompletedNCT01335607Phase 1
- A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C SubjectsTerminatedNCT01332552Phase 1
- A Study of Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis CCompletedNCT01331850Phase 2
- Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C TreatmentStatus unknownNCT01329952
- Safety, Pharmacokinetics, and Pharmacodynamics of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003)CompletedNCT01329913Phase 1
- Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis CStatus unknownNCT01327729Phase 2/3
- Entecavir for Chronic Hepatitis BCompletedNCT01323452
- TMC435-TiDP16-C115 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Erythromycin and Between TMC435 and Darunavir/Ritonavir (DRV/r)CompletedNCT01323257Phase 1
- A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 StudyCompletedNCT01323244Phase 3
- Behavioral Science Aspects of Rapid Test AcceptanceCompletedNCT01317784Not applicable
- A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus InfectionCompletedNCT01316237Phase 1
- Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)TerminatedNCT01316185Phase 1
- The Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug TestStatus unknownNCT01312012Phase 4
- Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis BCompletedNCT01311947
- Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With RituximabCompletedNCT01311232
- Extension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCVCompletedNCT01310205
- The Development of Diagnostic Biomarker Panels for Hepatitis and Liver CancerStatus unknownNCT01310062
- Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With RibavirinCompletedNCT01309932Phase 2
- TMC435-TiDP16-C116 - Relative Bioavailability and Food Effect StudyCompletedNCT01308606Phase 1
- Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR VaccinesCompletedNCT01307436Phase 3
- A Study of the Safety of Individualized Combination Therapy With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C (MASTER)WithdrawnNCT01296971Phase 3
- Study on Immunopathogenesis in HIV and Hepatitis C CoinfectionCompletedNCT01296529
- Study of a New MVA Vaccine for Hepatitis C VirusCompletedNCT01296451Phase 1
- HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in ChinaCompletedNCT01293279
- Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant RecipientsCompletedNCT01292824Phase 1
- Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis CCompletedNCT01292161Phase 2
- Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C PatientsCompletedNCT01290965Phase 1
- Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic CirrhosisCompletedNCT01289951Phase 1
- The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive IndividualsStatus unknownNCT01289652
- Ribavirin Dose Optimization for the Treatment of Hepatitis CCompletedNCT01289496Phase 2
- Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult SubjectsStatus unknownNCT01289106Phase 3
- TMC435-TiDP16-C108 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Digoxin and Between TMC435 and RosuvastatinCompletedNCT01288742Phase 1
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas)CompletedNCT01283074
- A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir With or Without Copegus (Ribavirin) in Interferon-Naïve Patients With Chronic Hepatitis C Genotype 1 (INFORM-SVR)CompletedNCT01278134Phase 2
- A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.CompletedNCT01277692Phase 1
- Examining the Immune Response in Patients With Gaucher Disease and Hepatitis CStatus unknownNCT01274208
- Vitamin D Deficiency in Subjects With Chronic Hepatitis C Compared to Healthy VolunteersWithdrawnNCT01274013
- Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 InfectionCompletedNCT01273948Phase 1/2
- Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infectionStatus unknownNCT01273142
- Prohepcidin, Inflammation and Iron Homeostasis in Hemodialysis Patients With Chronic Hepatitis CCompletedNCT01272479
- Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.Status unknownNCT01272310Phase 1/2
- A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis CCompletedNCT01271790Phase 2
- Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation TherapyStatus unknownNCT01270178
- Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis BStatus unknownNCT01270165Phase 3
- TMC435-TiDP16-C117: The Effect of TMC435 on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy VolunteersCompletedNCT01269294Phase 1
- A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV PatientsTerminatedNCT01266005Phase 4
- A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)CompletedNCT01264367Phase 4
- An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BCompletedNCT01264354Phase 4
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BTerminatedNCT01264133Phase 4
- An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received ClevudineCompletedNCT01264107
- A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long PeriodTerminatedNCT01264094Phase 4
- Hepatitis B Research Network Pediatric Cohort Study (HBRN)CompletedNCT01263600
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCCCompletedNCT01263002Phase 4
- Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B PatientsWithdrawnNCT01260610Not applicable
- Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination SchedulesCompletedNCT01259453Phase 4
- Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral TherapyCompletedNCT01258686Phase 3